Literature DB >> 33797804

Advances in biochemistry and the biotechnological production of taxifolin and its derivatives.

Nguyen Huy Thuan1, Anil Shrestha2, Nguyen Thanh Trung1, Vinay Bharadwaj Tatipamula1, Duong Van Cuong3, Nguyen Xuan Canh4, Nguyen Van Giang4, Tae-Su Kim5, Jae Kyung Sohng5, Dipesh Dhakal6.   

Abstract

Taxifolin (dihydroquercetin) and its derivatives are medicinally important flavanonols with a wide distribution in plants. These compounds have been isolated from various plants, such as milk thistle, onions, french maritime, and tamarind. In general, they are commercially generated in semisynthetic forms. Taxifolin and related compounds are biosynthesized via the phenylpropanoid pathway, and most of the biosynthetic steps have been functionally characterized. The knowledge gained through the detailed investigation of their biosynthesis has provided the foundation for the reconstruction of biosynthetic pathways. Plant- and microbial-based platforms are utilized for the expression of such pathways for generating taxifolin-related compounds, either by whole-cell biotransformation or through reconfiguration of the genetic circuits. In this review, we summarize recent advances in the biotechnological production of taxifolin and its derivatives.
© 2021 International Union of Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  astilbin; chemical; metabolism; pharmaceutical activity; taxifolin

Mesh:

Substances:

Year:  2021        PMID: 33797804     DOI: 10.1002/bab.2156

Source DB:  PubMed          Journal:  Biotechnol Appl Biochem        ISSN: 0885-4513            Impact factor:   2.431


  2 in total

Review 1.  Secondary Metabolites with Biomedical Applications from Plants of the Sarraceniaceae Family.

Authors:  Ileana Miclea
Journal:  Int J Mol Sci       Date:  2022-08-30       Impact factor: 6.208

2.  Effect of taxifolin on methotrexate-induced oxidative and inflammatory oral mucositis in rats: biochemical and histopathological evaluation.

Authors:  Zeynep Bayramoglu; Behzad Mokhtare; Ali Sefa Mendil; Taha Abdulkadir Coban; Renad Mammadov; Seval Bulut; Zeynep Suleyman; Halis Suleyman
Journal:  J Appl Oral Sci       Date:  2022-09-19       Impact factor: 3.144

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.